about
Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominancePathogen DiscoveryT cells with regulatory activity in hepatitis C virus infection: what we know and what we don'tSilymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infectionAccumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C.Interactions between Th1 cells and Tregs affect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway.Chemokines in the immunopathogenesis of hepatitis C infectionAutophagy in HCV infection: keeping fat and inflammation at bayCirculating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C.Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.Immunomodulatory effects of transforming growth factor-β in the liver.Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs.Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression.Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infectionIncreased baseline proinflammatory cytokine production in chronic hepatitis C patients with rapid virological response to peginterferon plus ribavirin.Macrophages in hepatitis B and hepatitis C virus infectionsThe role of chemokines in acute and chronic hepatitis C infection.The role of chemokines in hepatitis C virus-mediated liver diseaseExtra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis.Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication.Hepatic NK cell-mediated hypersensitivity to ConA-induced liver injury in mouse liver expressing hepatitis C virus polyprotein.F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C.Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotype.Monocyte adhesion molecules expression in patients with chronic hepatitis C liver disease.Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis.Ribavirin modulates the conversion of human CD4(+) CD25(-) T cell to CD4(+) CD25(+) FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cell.SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection.NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4(+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatmHepatitis C virus: Morphogenesis, infection and therapy.Liver HLA-E Expression Is Associated with Severity of Liver Disease in Chronic Hepatitis C.
P2860
Q26777659-47C80C2B-7C82-4D44-8359-BC4514B37B3FQ27485887-D1870AF6-8EDC-4517-8B30-454A8F4B24BEQ27486637-00D9B25D-2290-489A-AE19-A9BF2AF681B5Q27490911-68D1E0E2-A9A1-4023-BA53-2208599ECA40Q33402906-3601D055-80CE-43C2-90C7-35A6E674CCF7Q33721369-0A533951-34BB-4013-9A02-1819B8627B42Q34056271-7622019B-5C2F-4F30-BF11-8C59A15D4585Q34069393-958693A2-BDCA-438D-BC2D-BFEC2B5A1FBEQ34271108-7A0328D7-63DA-476A-B097-6D4E18737F2AQ34359514-6F763EFC-5B66-4AC0-B787-822265F61A09Q34648954-6AE5B6F1-BF07-4E31-B3D8-3115D4EEE4DFQ34673075-ECBD071D-6FBA-4A84-99FB-9E26B72F971AQ34750481-B66B487C-C3A5-4EF8-8F40-981C4DE5B36EQ35033949-2CAF9F42-3677-4833-BD89-48C6D8C5E0A1Q35044131-C94FFED6-9BFC-4EC4-8B6F-65007B7FC1C5Q35085189-DE03A9EB-94B5-4DE1-9932-0C5AF6B26566Q36461601-E36F5405-7512-4E94-859F-3631F5736E61Q36996953-5E1556C9-2C93-4812-8018-4DE773EB0FCDQ37289610-4860D266-2926-477C-B671-911281DD8D93Q38129709-318AF26B-41FB-4722-B922-7EA949BC8955Q38197441-176BDAF6-7CF6-4F9B-9CF7-943876ABDCE0Q39066204-09B2A190-E868-4C4C-A2F4-E31CCB565601Q39413236-E808FC51-638B-4286-8EAA-41EF27C1FDE3Q40053221-1E01948F-299E-45DD-8DA2-378E76B21407Q41344021-45CA1DDC-DBC0-4C10-B3A4-15B9DB68228AQ41563730-19C3B247-3AC1-4D93-9B40-57F3DE58B1ABQ42263903-E32AE754-14DE-4C3D-8D8B-2CE582D99099Q42350834-876DED05-3E56-4ED6-954C-799F7A457787Q43596899-2CCE1E51-E58D-4409-8454-B7B4D7E89338Q45355954-D1DA2819-928D-4565-8B62-932029A44147Q47980556-9E605DAB-826A-4D6B-8B0F-50BAB570EB15Q50559686-1231DBD7-F741-4BCA-93E5-3EDD9341C82CQ52661702-1A4A961C-6F33-4F46-B69B-8BB7DC87431BQ55410299-557D48FC-ED88-4566-B48E-BEB7E5F7F516
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immunopathogenesis in hepatitis C virus cirrhosis.
@ast
Immunopathogenesis in hepatitis C virus cirrhosis.
@en
type
label
Immunopathogenesis in hepatitis C virus cirrhosis.
@ast
Immunopathogenesis in hepatitis C virus cirrhosis.
@en
prefLabel
Immunopathogenesis in hepatitis C virus cirrhosis.
@ast
Immunopathogenesis in hepatitis C virus cirrhosis.
@en
P356
P1433
P1476
Immunopathogenesis in hepatitis C virus cirrhosis.
@en
P2093
Jacob Nattermann
Ulrich Spengler
P304
P356
10.1042/CS20060171
P407
P577
2007-02-01T00:00:00Z